Nuplazid (pimavanserin) is an atypical antipsychotic which is approved for the treatment of Parkinson’s disease psychosis and is also being researched for the treatment of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.